Fundraising FoxGilde Healthcare — 2024 Investments
6 investments dated 2024 · listed companies and verified rows first · show all
Draupnir Bio develops targeted protein degradation therapies using sortilin-based lysosome targeting chimeras to clear extracellular and membrane-bound protein aggregates in proteinopathies.
BiotechDeep TechMedical DevicesCopenhagen, DK
Simon Glerup(Professor)inCamilla Gustafsen(Professor)inPeder Søndergaard Madsen(Professor)Peter Seeberger(Professor)
Co-investorsInkefMC Healthcare VenturesNovo Holdings
Purespring develops genetic therapies targeting podocytes to treat renal diseases through its proprietary GlomThera platform.
BiotechDigital HealthHealthtechMedical Devices
Moin Saleem(Co-founder & Chief Scientific Advisor)in
Co-investorsSofinnova PartnersForbionAdvent Life SciencesBritish Patient Capital
Argá Medtech is developing a non-thermal cardiac ablation system based on a proprietary Pulsed Field Ablation (PFA) technology using sine wave energy and a proprietary catheter to treat atrial fibrillation and other heart arrhythmias.
HardwareHealthtechMedical Devices
Co-investorsAdvent Life SciencesHigh Tech GruenderfondsHTGFEarlybird Venture Capital
Elmsford, US
Jonathan Taqqu(Executive Officer, Director)
BoardJohn Lee(Director)
Co-investorsHealthy Ventures.406 VenturesAlleyCorpCVS Health VenturesSandbox Clinical Ventures
Mainstay provides an AI-powered platform that enables higher education institutions to engage students through proactive, personalized coaching and messaging.
AI & Machine LearningEdTechHR TechSaaSArlington, US
Andrew Magliozzi(Founder)inKirk Daulerio(Co-Founder, Vice President, Community)in
BoardKEVIN TALBOT(Director)
Co-investorsAlumni VenturesBisk VenturesEastward Capital PartnersFundersClubK Street CapitalMichelson 20MM Foundation+12 more
Irish company developing an advanced neurostimulation device.
HealthtechPlymouth, US
Dan Sachs(Director)Peter Crosby(Executive Officer, Director)inJason Hannonin
BoardManus Rogan(Director)inAntoine Papiernik(Director)in
Co-investorsFountain Healthcare PartnersIreland Strategic Investment FundSeventure PartnersSofinnova PartnersViking GlobalAlly Bridge Group+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.